z-logo
open-access-imgOpen Access
Rapid Screening for Carbapenem Resistant Organisms: Current Results and Future Approaches
Author(s) -
Shalini Anandan,
Sunganya Damodaran,
Radha Gopi,
Yamuna Devi Bakthavatchalam,
Balaji Veeraraghavan
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/14246.6530
Subject(s) - klebsiella pneumoniae , multiplex , multiplex polymerase chain reaction , microbiology and biotechnology , carbapenem , carbapenem resistant enterobacteriaceae , enterobacteriaceae , feces , biology , escherichia coli , polymerase chain reaction , gene , antibiotics , bioinformatics , genetics
Carbapenem producing Enterobacteriaceae (CPE) is a major public health threat. A total of 120 carbapenem resistant E.coli (n=32) and K.pneumoniae (n=88) from blood stream infections were screened for the presence of carbapenem resistant genes KPC, NDM, IMP, VIM, and OXA-48 like using both conventional multiplex PCR and Xpert(®) Carba-R test. Additionally 26 faeces samples were directly screened with Xpert(®) Carba-R test. Of the tested isolates, 40% (n=48) of NDM and 39.2% (n=47/) of OXA-48-like were identified. Co-production of OXA-48 and NDM was seen in 15 (12.5%) isolates. In Xpert(®) Carba-R test, only NDM was identified in 55% (n=66) of tested isolates. Of the tested faeces samples, 12 were identified as carbapenemase producers: nine with NDM, two with the co-production of NDM and VIM and in Klebsiella spp (n=1), NDM and KPC co-production was seen. However, Xpert(®) Carba-R test fails to detect OXA-48 like as compared with multiplex PCR. The sensitivity, specificity, PPV, NPV of Xpert(®) Carba-R test was 100%, 77%, 96% and 100% respectively. Incorporation of OXA-48 like specific sequence in the panel of Xpert(®) Carba-R test may improve its sensitivity and maximize the coverage of assay.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here